Tumor-associated immune parameters for personalized patient care.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24307691.
- Also identified by DOI 10.1126/scitranslmed.3007942.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The implementation of a robust technology adapted to clinical practice for the evaluation of the tumor-immune infiltrate is required to exploit its prognostic and theranostic value (Robins et al., this issue).
Medical subject headings
- Biomarkers, Tumor
- Genomics
- Immunity, Cellular
- Lymphocytes, Tumor-Infiltrating
- Ovarian Neoplasms
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma